Abstract: A compound comprising a structure of Formula I, In Formula I, moiety C is a monocyclic ring or a polycyclic fused ring system; each of Z1-Z2 and X1—X9 is C or N; Y1 is C, N, O, S, Se, P, or As; if Y1 is O, S, or Se, then either A2, R4, and L3 are absent or A1, R3, and L2 are absent; K is a direct bond or a linker; each of A1 and A2 is C, B, Ge, S, Si, N, P, or As; each of L1, L2, and L3 is absent, a direct bond, or a linker; at least two of L1, L2, and L3 are present; metal M is Pd or Pt; and each R, R?, R*, R1, R2, R3, R4, RA, RB, RC, R?, and R? is hydrogen or a General Substituent defined herein. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound is disclosed that is selected from the group consisting of a structure having and a structure having

Abstract: A compound comprising a structure of Formula I, is provided. In Formula I, RW has a structure of Formula II, where at least two RE substituents are joined to form a 5- to 10-membered ring; each of X1 to X11 and Z1 to Z3 is C or N; M is Pd or Pt; each of moiety A, moiety B, moiety C, and moiety D is a ring or a polycyclic fused ring system; each of L1 and L2 is a direct bond or a linker; each substituent is hydrogen or a General Substituents defined herein; and any two substituents may be joined or fused to form a ring, Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound comprising a first ligand LA of Formula I, In Formula I, X1 to X7 are each C or N; K1 is a direct bond or a linker; R1 and R2 are substituents; each R3, R4, R5, R?, R?, RA, RB, and RC is hydrogen or a General Substituent defined herein; LA is coordinated to a metal M; when R1 is substituted or unsubstituted aryl, specific conditions must be met, and when R1 is alkyl, other conditions must be met. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Disclosed are platinum or palladium complexes featuring tetradentate ligands with at least one side that has an NN binding motif are disclosed. The disclosed organometallic compounds have a structure of where M is Pt or Pd. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Compounds of are provided. In these structures, M is Pt or Pd; each of X1 to X6, X9 to X12, and Z1 to Z3 is C or N; each of L1, L2, L3, and L4 is a direct bond or a linker; at least three of L1, L2, L3, and L4 are present; each K1, K2, and K3 is a bond, O, or S; when Z1 is N, ring A in Formula I is not a pyridine or pyrazole; L? is a bond or an organic linker; Y is selected from the group consisting of amino, alkoxy, aryloxy, or SiR1R2R3; when Y is SiR1R2R3, L2 is not BR. Devices, consumer products, and formulations containing these compounds are also disclosed.

Abstract: Provided are organometallic compounds comprising an at least bidentate ligand comprising at least five cyclic moieties and a central metal ion which is preferably Ir or Pt. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.

Abstract: A compound having the following formula is disclosed. The compound is useful as an emitter in OLED applications.

Abstract: A compound of Formula I, is provided. In Formula I, one of Z1, Z2, and Z3 is N and the remainder are C; each of L1 and L2 is independently selected from a direct bond and a linking group; at least one of R1, R2, RA, RB, RC, RD, and RE comprises a group R* having a structure selected form the group consisting of Formula II, -Q(R3)(R4)a(R5)b, Formula III, and Formula IV, Each R, R?, R?, R1, R2, R3, R4, R5, RA, RB, RC, RD, RE, RF, RG, and RH is independently hydrogen or a General Substituent, with the proviso that group R* is not adamantyl. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound is disclosed that is selected from the group consisting of a structure having and a structure having

Abstract: In one aspect, provided is a compound of Formula I, In Formula I, M is Pt or Pd; L has the structure F1 is or a direct bond; rings A, B, C, D, and F are independently monocyclic rings or multicyclic fused ring systems; each of X1 to X10 is independently C or N; each of Z1 to Z4 is C or N; each of L1 to L5 is a direct bond or an organic linker, each of a, b, c, and d is 0 or 1; each K1 to K4 is a direct bond, O, or S; each of Z1 to Z4 that is connected to O or S is C; and each RA, RB, RC, RD, RE, and RX is independently hydrogen or a substituent.

Abstract: Tetradentate platinum complexes comprising an imidazole/benzimidazole carbene having a structure of Formula I is disclosed. In Formula I, M is Pd or Pt. These platinum carbenes with the specific substituents disclosed herein are novel and provides phosphorescent emissive compounds that exhibit physical properties that can be tuned, such as sublimation temperature, emission color, and device stability.

Abstract: A compound having the following formula is disclosed. The compound is useful as an emitter in OLED applications.

Abstract: Disclosed is a compound of Formula I: useful as emitters in OLEDs; where the variables in Formula I are defined in the present disclosure.

Abstract: A compound is disclosed that is selected from the group consisting of a structure having Formula I and a structure having Formula II

Abstract: A novel compound having a benzimidazole based structure is disclosed that is selected from one of the following structures: The compound is useful in improving photophysical performance of OLEDs.

Abstract: A compound of Formula I, is provided. In Formula I, one of Z1, Z2, and Z3 is N and the remainder are C; each of L1 and L2 is independently selected from a direct bond and a linking group; at least one of R1, R2, RA, RB, RC, RD, and RE comprises a group R* having a structure selected form the group consisting of Formula II, -Q(R3)(R4)a(R5)b, Formula III, and Formula IV, Each R, R?, R?, R1, R2, R3, R4, R5, RA, RB, RC, RD, RE, RF, RG, and RH is independently hydrogen or a General Substituent, with the proviso that group R* is not adamantyl. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound of Formula I, is provided. In Formula I, one of Z1, Z2, and Z3 is N and the remainder are C; each of L1 and L2 is independently selected from a direct bond and a linking group; at least one of R1, R2, RA, RB, RC, RD, and RE comprises a group R* having a structure selected form the group consisting of Formula II, -Q(R3)(R4)a(R5)b, Formula III, and Formula IV, Each R, R?, R?, R1, R2, R3, R4, R5, RA, RB, RC, RD, RE, RF, RG, and RH is independently hydrogen or a General Substituent, with the proviso that group R* is not adamantyl. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: In one aspect, provided is a compound of Formula I, In Formula I, M is Pt or Pd; L has the structure F1 is or a direct bond; rings A, B, C, D, and F are independently monocyclic rings or multicyclic fused ring systems; each of X1 to X10 is independently C or N; each of Z1 to Z4 is C or N; each of L1 to L5 is a direct bond or an organic linker; each of a, b, c, and d is 0 or 1; each K1 to K4 is a direct bond, O, or S; each of Z1 to Z4 that is connected to O or S is C; and each RA, RB, RC, RD, RE, and RX is independently hydrogen or a substituent.

Abstract: Compounds of Formula I, and Formula IIa, Formula IIb, are provided. In these structures, M is Pt or Pd; each of X1 to X6, X9 to X12, and Z1 to Z3 is C or N; each of L1, L2, L3, and L4 is a direct bond or a linker; at least three of L1, L2, L3, and L4 are present; each K1, K2, and K3 is a bond, O, or S; when Z1 is N, ring A in Formula I is not a pyridine or pyrazole; L5 is a bond or an organic linker; Y is selected from the group consisting of amino, alkoxy, aryloxy, or SiR1R2R3; when Y is SiR1R2R3, L2 is not BR. Devices, consumer products, and formulations containing these compounds are also disclosed.